Vascular Biogenics Inc. (VBLT) stock rises during after-hour session. What has been happening?
Vascular Biogenics Inc. (NASDAQ: VBLT) stock declined by 8.33% at the last close whereas the VBLT stock price gained by 5.37% in the after-hours session. VBL Therapeutics, a subsidiary of Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical business focusing on the research, production, and marketing of first-in-class medicines for cancer and immune/inflammatory diseases. Recent Development […]